作者
Gabriel Chodick, Lilac Tene, Tal Patalon, Sivan Gazit, Amir Ben Tov, Dani Cohen, Khitam Muhsen
发表日期
2021/6/1
期刊
JAMA network open
卷号
4
期号
6
页码范围
e2115985-e2115985
出版商
American Medical Association
简介
Importance
The BNT162b2 vaccine showed high efficacy against COVID-19 in a phase III randomized clinical trial. A vaccine effectiveness evaluation in a real-world setting is needed.
Objective
To assess the short-term effectiveness of the first dose of the BNT162b2-vaccine against SARS-CoV-2 infection 13 to 24 days after immunization in a real-world setting.
Design, Setting, and Participants
This comparative effectiveness study used data from a 2.6 million-member state-mandated health care system in Israel. Participants included all individuals aged 16 years and older who received 1 dose of the BNT162b2 vaccine between December 19, 2020, and January 15, 2021. Data were analyzed in March 2021.
Exposure
Receipt of 1 dose of the BNT162b2 vaccine.
Main Outcomes and Measures
Information was collected regarding medical history and positive SARS-CoV-2 polymerase chain reaction test and COVID-19 …
学术搜索中的文章
G Chodick, L Tene, T Patalon, S Gazit, AB Tov… - JAMA network open, 2021